Skip to search formSkip to main contentSkip to account menu

KE 758

Known as: KE-758 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
KE-758, an active metabolite of KE-298, is a novel sulfhydryl antirheumatic drug. We analyzed the effect of KE-758 on tumor… 
2001
2001
OBJECTIVE To analyze the effects of KE-298 and KE-758 on lipopolysaccharide (LPS) induced nitric oxide (NO) production by the… 
1996
1996
KE-298(2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid) is a newly developed antirheumatic drug which suppresses the… 
1993
1993
Rheumatoid synovial tissue produces excessive amounts of interleukin-6 (IL-6), which contributes to the immunopathogenesis of…